Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Andreoni and Sandro Grelli.
Connection Strength
0.344
-
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Mult Scler Relat Disord. 2021 Oct; 55:103157.
Score: 0.060
-
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine. 2021 Apr; 66:103341.
Score: 0.059
-
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa588.
Score: 0.057
-
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. Heliyon. 2020 Oct; 6(10):e05143.
Score: 0.057
-
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020 09 11; 14(1):29.
Score: 0.056
-
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov. 2020; 6:38.
Score: 0.055